June 15, 2020 Sophia Vida
Biotech & Pharma

Novavax to Raise Capital through $200M Stock Offering to Fund COVID-19 Vaccine

American vaccine development company Novavax announced on Monday that it would raise fresh capital through a $200 million preferred stock offering. The move is to help the company rush to develop a vaccine for the new coronavirus. Shares of Novavax were up 10.5% on the news. The private placement to investment fund RA Capital Management … Continue reading “Novavax to Raise Capital through $200M Stock Offering to Fund COVID-19 Vaccine”